Literature DB >> 3125676

Characterization of mononuclear exudates in idiopathic inflammatory myopathies.

J C Botet1, J M Grau, J Casademont, A Urbano-Márquez, C Rozman.   

Abstract

Percentages of B-cells, T-cells and subsets Th, Ts, T activated, and macrophages were analyzed by using monoclonal antibodies in a series of 24 patients [19 dermatomyosis (DM) and 5 polymyositis (PM)]. Specific site of deposition of these cells was also identified (endomysial, perimysial and perivascular). We were able to find a greater number of endomysial T-cells in PM than in DM. However, B-cells were more frequent at perivascular sites in DM than in PM. These findings support the previous reported hypothesis that humorally-mediated immune damage in both vascular and muscle cells predominates in DM while cellular cytotoxic mediated damage is more marked in PM patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125676     DOI: 10.1007/bf00750264

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  10 in total

1.  The childhood type of dermatomyositis.

Authors:  S Carpenter; G Karpati; S Rothman; G Watters
Journal:  Neurology       Date:  1976-10       Impact factor: 9.910

2.  Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies.

Authors:  A G Engel; K Arahata
Journal:  Hum Pathol       Date:  1986-07       Impact factor: 3.466

3.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

4.  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy.

Authors:  J N Whitaker; W K Engel
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

5.  Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis.

Authors:  A G Engel; K Arahata
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

6.  Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

7.  Inflammatory myopathy associated with chronic graft-versus-host disease.

Authors:  A Urbano-Márquez; R Estruch; J M Grau; A Grañena; E Martín-Ortega; J Palou; C Rozman
Journal:  Neurology       Date:  1986-08       Impact factor: 9.910

8.  Immunohistochemical characterization of the mononuclear cells infiltrating muscle of patients with inflammatory and noninflammatory myopathies.

Authors:  R Giorno; M T Barden; P F Kohler; S P Ringel
Journal:  Clin Immunol Immunopathol       Date:  1984-03

9.  Microvascular deposition of complement membrane attack complex in dermatomyositis.

Authors:  J T Kissel; J R Mendell; K W Rammohan
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

10.  Characterization of polymyositis infiltrates using monoclonal antibodies to human leucocyte antigens.

Authors:  D J Rowe; D A Isenberg; J McDougall; P C Beverley
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

  10 in total
  2 in total

Review 1.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.

Authors:  Gilmara Franco da Cunha; Fernando Henrique Carlos de Souza; Maurício Levy-Neto; Samuel Katsuyuki Shinjo
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.